PTE News and Press, PolarityTE Inc. From 05/01/20

Axcella Health (NASDAQ: AXLA ) initiated with Buy rating and $10 (115% upside) price target at BTIG Research. More news on: Axcella Health Inc., Viking Therapeutics, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

PolarityTE, Inc. (Nasdaq: PTE) is providing an update on a change to the strategic focus of the Company and the regulatory pathway for the Company’s SkinTE™ product. PolarityTE has decided to pursue a plan to submit an investigational new drug application (IND) and thereaf...

PolarityTE (NASDAQ: PTE ) provides corporate update and preliminary Q1 2020 results. More news on: PolarityTE, Inc., Healthcare stocks news, , Read more ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, is providing an update on actions the Company is taking to best position the business and support the Company’s stakeholders in light of the COVID-19 ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that data from its Head-to-Head Burn trial was published in the Journal of Burn Care & Research . This abstract was accepted for a podiu...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it has received correspondence from the United States Securities and Exchange Commission (“SEC”) advising PolarityTE that ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of Chris Nolet to the Company’s Board of Directors and Chair of the Audit Committee. Mr. Nolet brings extensive audit ...

Aimed at establishing a more traditional management structure, PolarityTE (NASDAQ: PTE ) has dissolved the Office of the Chief Executive and appointed David Seabury as CEO while COO Richard Hague will also serve as President. More news on: PolarityTE, Inc., Healthcare stocks news, Stocks...

Richard Hague appointed President and will continue as Chief Operating Officer PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that the Company’s Board of Directors has restru...

PolarityTE, Inc. (PTE) Q4 2019 Results Earnings Conference Call March 12, 2020, 08:00 AM ET Company Participants Rich Haerle - Vice President of Investor Relations David Seaburg - President Paul Mann - Chief Financial Officer Richard Hague - Chief Operating Officer Nikolai So...